SEC Form 4 · accession 0001104659-26-076922
NOVAVAX INC · NVAX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles W. Newton
Director
Period of report
Jun 18, 2026
Accepted (ET)
Jun 23, 2026 · 7:49 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001000694
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $9.13 | Jun 18, 2026 | A | 21,270 | A | — | Jun 18, 2036 | Common Stock | 21,270 | 21,270 | D |
| Restricted Stock UnitsF2,F3 | — | Jun 18, 2026 | A | 14,180 | A | — | — | Common Stock | 14,180 | 14,180 | D |
Explanation of responses
- F1One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date.
- F2Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
- F3One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date.